BIIB vs PTC · P/E 21, rev $9.89B vs P/E 48, rev $2.74B
Biogen Inc (BIIB) versus PTC Inc (PTC) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
PTC Inc (PTC) is a software - application company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Not investment advice. Open the BIIB and PTC stock pages for the full models.
Not investment advice.